Cargando…

Abnormal TNS3 gene methylation in patients with congenital scoliosis

BACKGROUND: Congenital scoliosis (CS) is a congenital deformity of the spine resulting from abnormal and asymmetrical development of vertebral bodies during pregnancy. However, the etiology and mechanism of CS remain unclear. Epigenetics is the study of heritable variations in gene expression outsid...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, YuanTao, Zhang, Hong-qi, Tang, Mingxing, Guo, Chaofeng, Liu, Shaohua, Li, Jiong, Wang, Yunjia, Xiao, Lige, Yang, Guanteng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392296/
https://www.ncbi.nlm.nih.gov/pubmed/35987623
http://dx.doi.org/10.1186/s12891-022-05730-x
_version_ 1784771031914774528
author Wu, YuanTao
Zhang, Hong-qi
Tang, Mingxing
Guo, Chaofeng
Liu, Shaohua
Li, Jiong
Wang, Yunjia
Xiao, Lige
Yang, Guanteng
author_facet Wu, YuanTao
Zhang, Hong-qi
Tang, Mingxing
Guo, Chaofeng
Liu, Shaohua
Li, Jiong
Wang, Yunjia
Xiao, Lige
Yang, Guanteng
author_sort Wu, YuanTao
collection PubMed
description BACKGROUND: Congenital scoliosis (CS) is a congenital deformity of the spine resulting from abnormal and asymmetrical development of vertebral bodies during pregnancy. However, the etiology and mechanism of CS remain unclear. Epigenetics is the study of heritable variations in gene expression outside of changes in nucleotide sequence. Among these, DNA methylation was described first and is the most characteristic and most stable epigenetic mechanism. Therefore, in this study, we aim to explore the association between genome methylation and CS which are not been studied before. METHODS: Two pairs of monozygotic twins were included, with each pair involving one individual with and one without CS. Agilent SureSelect XT Human Methyl-Sequencing was used for genome methylation sequencing. MethylTarget was used to detect methylation levels in target regions. Immunohistochemistry was performed to visualize expression of associated genes in candidate regions. RESULTS: A total of 75 differentially methylated regions were identified, including 24 with an increased methylation level and 51 with a decreased methylation level in the CS group. Nine of the differentially methylated regions were selected (TNS3, SEMAC3, GPR124, MEST, DLK1, SNTG1, PPIB, DEF8, and GRHL2). The results showed that the methylation level of the promoter region of TNS3 was 0.72 ± 0.08 in the CS group and 0.43 ± 0.06 in the control group (p = 0.00070 < 0.01). There was no significant difference in the degree of methylation of SEMAC3, GPR124, MEST, DLK1, SNTG1, PPIB, DEF8, or GRHL2 between the two groups. Immunohistochemistry showed significantly decreased TNS3 expression in the cartilage of the articular process in CS (CS: 0.011 ± 0.002; control: 0.018 ± 0.006, P = 0.003 < 0.01). CONCLUSION: Compared with the control group, high-level methylation of the TNS3 promoter region and low TNS3 expression in the cartilage layer of the articular process characterize CS. Thus, DNA methylation and TNS3 may play important roles in the pathogenesis of CS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-022-05730-x.
format Online
Article
Text
id pubmed-9392296
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93922962022-08-21 Abnormal TNS3 gene methylation in patients with congenital scoliosis Wu, YuanTao Zhang, Hong-qi Tang, Mingxing Guo, Chaofeng Liu, Shaohua Li, Jiong Wang, Yunjia Xiao, Lige Yang, Guanteng BMC Musculoskelet Disord Research BACKGROUND: Congenital scoliosis (CS) is a congenital deformity of the spine resulting from abnormal and asymmetrical development of vertebral bodies during pregnancy. However, the etiology and mechanism of CS remain unclear. Epigenetics is the study of heritable variations in gene expression outside of changes in nucleotide sequence. Among these, DNA methylation was described first and is the most characteristic and most stable epigenetic mechanism. Therefore, in this study, we aim to explore the association between genome methylation and CS which are not been studied before. METHODS: Two pairs of monozygotic twins were included, with each pair involving one individual with and one without CS. Agilent SureSelect XT Human Methyl-Sequencing was used for genome methylation sequencing. MethylTarget was used to detect methylation levels in target regions. Immunohistochemistry was performed to visualize expression of associated genes in candidate regions. RESULTS: A total of 75 differentially methylated regions were identified, including 24 with an increased methylation level and 51 with a decreased methylation level in the CS group. Nine of the differentially methylated regions were selected (TNS3, SEMAC3, GPR124, MEST, DLK1, SNTG1, PPIB, DEF8, and GRHL2). The results showed that the methylation level of the promoter region of TNS3 was 0.72 ± 0.08 in the CS group and 0.43 ± 0.06 in the control group (p = 0.00070 < 0.01). There was no significant difference in the degree of methylation of SEMAC3, GPR124, MEST, DLK1, SNTG1, PPIB, DEF8, or GRHL2 between the two groups. Immunohistochemistry showed significantly decreased TNS3 expression in the cartilage of the articular process in CS (CS: 0.011 ± 0.002; control: 0.018 ± 0.006, P = 0.003 < 0.01). CONCLUSION: Compared with the control group, high-level methylation of the TNS3 promoter region and low TNS3 expression in the cartilage layer of the articular process characterize CS. Thus, DNA methylation and TNS3 may play important roles in the pathogenesis of CS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-022-05730-x. BioMed Central 2022-08-20 /pmc/articles/PMC9392296/ /pubmed/35987623 http://dx.doi.org/10.1186/s12891-022-05730-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wu, YuanTao
Zhang, Hong-qi
Tang, Mingxing
Guo, Chaofeng
Liu, Shaohua
Li, Jiong
Wang, Yunjia
Xiao, Lige
Yang, Guanteng
Abnormal TNS3 gene methylation in patients with congenital scoliosis
title Abnormal TNS3 gene methylation in patients with congenital scoliosis
title_full Abnormal TNS3 gene methylation in patients with congenital scoliosis
title_fullStr Abnormal TNS3 gene methylation in patients with congenital scoliosis
title_full_unstemmed Abnormal TNS3 gene methylation in patients with congenital scoliosis
title_short Abnormal TNS3 gene methylation in patients with congenital scoliosis
title_sort abnormal tns3 gene methylation in patients with congenital scoliosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392296/
https://www.ncbi.nlm.nih.gov/pubmed/35987623
http://dx.doi.org/10.1186/s12891-022-05730-x
work_keys_str_mv AT wuyuantao abnormaltns3genemethylationinpatientswithcongenitalscoliosis
AT zhanghongqi abnormaltns3genemethylationinpatientswithcongenitalscoliosis
AT tangmingxing abnormaltns3genemethylationinpatientswithcongenitalscoliosis
AT guochaofeng abnormaltns3genemethylationinpatientswithcongenitalscoliosis
AT liushaohua abnormaltns3genemethylationinpatientswithcongenitalscoliosis
AT lijiong abnormaltns3genemethylationinpatientswithcongenitalscoliosis
AT wangyunjia abnormaltns3genemethylationinpatientswithcongenitalscoliosis
AT xiaolige abnormaltns3genemethylationinpatientswithcongenitalscoliosis
AT yangguanteng abnormaltns3genemethylationinpatientswithcongenitalscoliosis